Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  10/29/2007
 
Trade Name:  Abilify
 
Generic or Proper Name (*):  aripiprazole
 
Indications Studied:  Schizophrenia
 
Therapeutic Category:  Antipsychotic
 
Ages Studied:  11- 17 years
 
Study #:  3
 
Study Type:  Efficacy/Safety
 
Study Design:  Single-Blind/Placebo/Parallel Group
 
No Patients:  302
 
No Centers:  101
 
No Countries:  13
 
BPCA(B), PREA(P):  B
 
Asian:  43
 
Black:  34
 
Other:  44
 
White:  180
 
Native Hawaiian or Pacific Islander:  1
 
American Indian/Alaska Native:  0
 
Hispanic/Latino:  41
 
Non-Hispanic/Non Latino:  261
 
-
-